Protagonist Therapeutics, Inc. · NASDAQ:PTGX

Deep Track Capital, LP's stake in Protagonist Therapeutics, Inc. fell to 2.76% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Deep Track Capital, LP's stake in Protagonist Therapeutics, Inc. fell to 2.76%, 1,715,691 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
2.76%
Shares
1,715,691
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP2.76%1,715,691
Deep Track Biotechnology Master Fund, Ltd.2.76%1,715,691
David Kroin2.76%1,715,691

Source

View original at SEC

Related